July 9, 2019

PetCure Oncology, a company providing veterinary cancer treatment utilizing noninvasive stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT), announced it has engaged Boustead Securities, LLC for a Regulation D 506(C) offering and other capital mark...

Please reload

Recent Posts
  • Boustead Securities LinkedIn
  • Facebook Basic Square
Please reload

Archive
Please reload

Search By Tags